| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 92E9B7675Y |
Structure
| InChI Key | IENZFHBNCRQMNP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C23H21ClFN5O4S |
| Molecular Weight | 517.97 |
| AlogP | 4.43 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 64.84 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 27.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Serotonin 2b (5-HT2b) receptor antagonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | 0.3583 |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hypertension; Hypertension, Pulmonary | Phase 2 | ClinicalTrials |
| Hypertension; Hypertension, Pulmonary; Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive | Phase 2 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL513994 |
| EPA CompTox | DTXSID60235710 |
| FDA SRS | 92E9B7675Y |
| PubChem | 11502243 |
| SureChEMBL | SCHEMBL1604039 |
| ZINC | ZINC000040403513 |
| ChEMBL | CHEMBL4297322 |
| DrugBank | DB05607 |
| FDA SRS | 92E9B7675Y |
| PubChem | 11502243 |
| SureChEMBL | SCHEMBL1604039 |
CONTENTS